Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Ann Allergy Asthma Immunol. 2019 Feb 10;122(4):381–386. doi: 10.1016/j.anai.2019.02.002

Table 5:

Odds of prior ICU admission with significant factors in unadjusted model forced into final model.

Valid % or mean (SD) or median [IQR] Odds of prior ICU admission compared to reference category

OR (95% CI), p-value

Income (<10 k vs. >=10 k per year) 2.25 (1.07-4.72), p=0.032
Mouse allergen (+ vs. −) 1.89 (0.90-3.97), p=0.093
Controller Therapy:
 No controller therapy Reference
 Monotherapy 1.28 (0.49-3.37), p=0.612
 Combination Therapy 2.63 (1.02-6.80), p=0.046
SABA (>=4 vs. <4 in past year) 1.61 (0.75-3.46), p=0.224